Key Study: Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial (2009)
Key Study: Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial (2009)
Visit VisitRationale: Vasopressin has been proposed as a potent vasoactive agent in the treatment of vasodilatory shock in adults and children. The objective of this trial was to evaluate the efficacy and safety of vasopressin as an adjunctive agent in pediatric vasodilatory shock. Published: 2009.
